Contrast agent augmented ultrasound therapy system with ultrasound imaging guidance for thrombus treatment

• US 20070167798A1
• Filed: 11/23/2005
• Published: 07/19/2007
• Est. Priority Date: 11/23/2005
• Status: Abandoned Application

• Current Assignee: Siemens Medical Solutions USA Incorporated (Siemens AG)
• Original Assignee: Siemens Medical Solutions USA Incorporated (Siemens AG)
• Inventors: Thomas, Lewis, Cai, Anming
• Application Number:
  US11/286,983
• Publication Number:
  US 20070167798A1
• Time in Patent Office: Days
• US Class Current: 600/458
• CPC Class Codes: A61B 5/02007 Evaluating blood vessel condition, e.g. elasticity, compliance
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 8/06 Measuring blood flow measuring volume flow in general G01F, e.g. G01F1/66, G01F1/72; measuring speed of fluids in general G01P5/00
• CPC Class Codes: A61B 8/0833 involving detecting or locating foreign bodies or organic structures
• CPC Class Codes: A61B 8/13 Tomography A61B8/10, A61B8/12 take precedence; tomography for radiation diagnosis A61B6/02
• CPC Class Codes: A61B 8/481 involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream analysis of echo signal exploiting properties of a contrast enhancer in devices for short-range imaging with acoustic waves G01S7/52039
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092

Abstract

Ultrasound diagnosis and therapy for disruption of a thrombus are provided with a same ultrasound system. A same transducer and system images contrast agents and ruptures the contrast agents to mechanically weaken or destroy a thrombus.

Claims

1. A method for contrast agent ultrasound imaging and therapy, the method comprising:

imaging a possible clot and contrast agents with an ultrasound transducer; and

driving the contrast agents at or adjacent to the possible clot with ultrasound pulses from the same ultrasound transducer.

2. The method of claim 1 wherein driving comprises transmitting high-MI ultrasound.

3. The method of claim 1 wherein driving comprises transmitting at least one pulse at a frequency about 2 MHz or below with a duration less than 50 microseconds.

4. The method of claim 1 wherein driving comprises transmitting pulses with a positive pressure occurring before a negative pressure in an initial cycle.

5. The method of claim 1 further comprising:

activating the driving act with a button on the ultrasound transducer or with a foot pedal.

6. The method of claim 1 wherein imaging comprises imaging with low-MI ultrasound.

7. The method of claim 1 wherein imaging comprises imaging the possible clot with a higher transmit level prior to injection of the contrast agents and imaging with a lower transmit level after injection of the contrast agent.

8. The method of claim 1 wherein imaging comprises generating images with lesser breaking of the contrast agents than the driving.

9. The method of claim 1 further comprising:

sweeping the possible clot during the driving.

10. The method of claim 1 further comprising:

repeating the imaging and driving until the possible clot is substantially not visible in the imaging.

11. The method of claim 1 wherein imaging comprises imaging a thrombosis.

12. The method of claim 1 wherein driving comprises releasing a drug from the contrast agents.

13. The method of claim 1 further comprising:

monitoring treatment.

14. In a computer readable storage medium having stored therein data representing instructions executable by a programmed processor for contrast agent ultrasound imaging and therapy, the storage medium comprising instructions for:

using one transducer to image a blood clot and contrast agents and to mechanically break or weaken the blood clot with disruption by at least some of the contrast agents.

15. The instructions of claim 14 wherein mechanically breaking or weakening the blood clot comprises transmitting ultrasound energy with a mechanical index above 1.2.

16. The instructions of claim 14 wherein mechanically breaking or weakening the blood clot comprises transmitting at least one pulse at a center frequency about 2 MHz or below with a duration less than 50 microseconds and a positive pressure occurring before a negative pressure in an initial cycle of the at least one pulse.

17. The instructions of claim 14 further comprising:

activating the breaking or weakening act in response to a button on the ultrasound transducer or with a foot pedal.

18. The instructions of claim 14 wherein imaging comprises imaging the blood clot with a higher transmit level prior to injection of the contrast agents, imaging with a lower transmit level after injection of the contrast agent, and interleaving the imaging with the breaking or weakening.

19. The instructions of claim 14 further comprising:

repeating the imaging and breaking or weakening until the blood clot is substantially not visible in the imaging, the imaging comprising, at least in part, monitoring a treatment.

20. A method for contrast agent ultrasound imaging and therapy, the method comprising:

first transmitting acoustic energy with an ultrasound transducer to a thrombosis, the transmitting being about 0.5 MI or less;

receiving, with the ultrasound transducer, acoustic energy in response to the first transmitting, the received acoustic energy responsive to contrast agents and the thrombosis;

second transmitting acoustic energy, with the ultrasound transducer, the transmitting being about 1.0 MI or more and operable to alter the contrast agents associated with the thrombosis.

21. The method of claim 20 wherein acoustic energy responsive to the second transmitting is not used for imaging.

22. The method of claim 20 wherein first transmitting and receiving comprise imaging with the ultrasound transducer and wherein second transmitting comprises applying mechanical contrast agent destruction therapy with the same ultrasound transducer.

23. The method of claim 20 wherein second transmitting comprises destroying the contrast agents, the contrast agents being mixed with or carrying a drug.